4//SEC Filing
Sandoval Elisabeth 4
Accession 0001209191-22-045653
CIK 0001566044other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:12 PM ET
Size
5.7 KB
Accession
0001209191-22-045653
Insider Transaction Report
Form 4
Sandoval Elisabeth
Director
Transactions
- Award
Stock Options
2022-08-10+20,500→ 20,500 totalExercise: $0.31Exp: 2032-08-10→ Common Stock (20,500 underlying)
Footnotes (1)
- [F1]Represents the annual award to non-executive directors of the Issuer, awarded on the date of the Issuer's annual meeting of stockholders. These options vest over a 12-month period in equal, monthly installments, ending August 10, 2023.
Documents
Issuer
VYNE Therapeutics Inc.
CIK 0001566044
Entity typeother
Related Parties
1- filerCIK 0001632295
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:12 PM ET
- Size
- 5.7 KB